EUVIMEDEUVIMED entdecken
Crossref

Protective effect of lycopene against tamoxifen-induced hepatotoxicity in albino rats

Elias Adikwu, NelsonClemente Ebinyo, Ozeke Benalayefa

Biomedical and Biotechnology Research Journal (BBRJ) · 2020 · 4 (1) · 69

DOI: 10.4103/bbrj.bbrj_3_20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical and Biotechnology Research Journal (BBRJ), 2020. Verfasst von Elias Adikwu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tamoxifen citrate (TAM) is a drug of choice for the treatment of hormone-dependent breast cancer, but its use has been associated with frequent hepatotoxicity.

Aim

This study evaluated the protective effect of lycopene (LYP) against hepatotoxicity induced by TAM in albino rats.

Methods

Adult female albino rats (200–250 g) were divided into eight groups of n = 5. Group 1 (control) received normal saline (0.2mL) intraperitoneally (i.p.), daily for 7 days. Groups 2–4 were treated daily with LYP (10 mg/kg, 20 mg/kg, and 40 mg/kg) (i.p.) for 7 days, respectively. Group 5 was treated daily with TAM (45 mg/kg) i.p. for 7 days. Groups 6–8 were supplemented daily with LYP (10 mg/kg, 20 mg/kg, and 40 mg/kg) before treatment with TAM (45 mg/kg) i.p. for 7 days, respectively. At the end of treatment, the rats were anesthetized and blood samples were collected and assessed for serum markers of liver function. Liver samples were harvested for histology and biochemical assessments.

Results

Significant (P < 0.001) elevations in serum and liver aminotransferases, lactate dehydrogenase, gamma glutamyl transferase, alkaline phosphatase, total bilirubin, and conjugated bilirubin levels were observed in TAM-treated rats when compared to control. Furthermore, significant (P < 0.001) elevations in liver malondialdehyde levels with significant (P < 0.001) decreases in glutathione peroxidase, superoxide dismutase, glutathione, and catalase levels were observed in TAM-treated rats when compared to control. Vascular congestion with necrotic materials and lipoid necrosis were observed in TAM-treated rats. However, TAM-induced hepatotoxicity was significantly attenuated in a dose-dependent fashion in rats supplemented with LYP 10 mg/kg (P < 0.05), 20 mg/kg (P < 0.01), and 40 mg/kg (P < 0.001) when compared to TAM.

Conclusion

LYP may have clinical application in hepatotoxicity caused by tamoxifen.

Zitieren

APA

Adikwu, E., Ebinyo, N., & Benalayefa, O. (2020). Protective effect of lycopene against tamoxifen-induced hepatotoxicity in albino rats. Biomedical and Biotechnology Research Journal (BBRJ), 4(1), 69. https://doi.org/10.4103/bbrj.bbrj_3_20

Vancouver

Adikwu E, Ebinyo N, Benalayefa O. Protective effect of lycopene against tamoxifen-induced hepatotoxicity in albino rats. Biomedical and Biotechnology Research Journal (BBRJ). 2020;4(1):69. doi:10.4103/bbrj.bbrj_3_20

BibTeX
@article{Adikwu2020,
  author = {Adikwu, Elias and Ebinyo, NelsonClemente and Benalayefa, Ozeke},
  title = {Protective effect of lycopene against tamoxifen-induced hepatotoxicity in albino rats},
  journal = {Biomedical and Biotechnology Research Journal (BBRJ)},
  year = {2020},
  volume = {4},
  number = {1},
  pages = {69},
  doi = {10.4103/bbrj.bbrj_3_20}
}
Kostenlos starten →